Literature DB >> 27383908

ADAMTS5 promotes murine adipogenesis and visceral adipose tissue expansion.

Dries Bauters, Ilse Scroyen, Rebecca Deprez-Poulain, H Roger Lijnen1.   

Abstract

Enhanced expression of the aggrecanase ADAMTS5 (A Disintegrin And Metalloproteinase with Thrombospondin type 1 motifs; member 5) has been observed in adipose tissue (AT) of obese rodents. Here, we have investigated the role of ADAMTS5 in adipogenesis, AT expansion and associated angiogenesis. In vitro differentiation of precursor cells into mature adipocytes was studied using murine embryonic fibroblasts (MEF) derived from wild-type (Adamts5(+/+)) and ADAMTS5 deficient (Adamts5(-/-)) mice, or 3T3-F442A preadipocytes with stable gene silencing of Adamts5. De novo adipogenesis was monitored by injection of 3T3-F442A cells with or without Adamts5 knockdown in Nude mice. Furthermore, Adamts5(+/+)and Adamts5(-/-) mice were kept on a high-fat diet (HFD) to monitor AT development. Adamts5(-/-) MEF, as well as 3T3-F442A preadipocytes with Adamts5 knockdown, showed significantly reduced differentiation as compared to control cells. In mice, de novo formed fat pads arising from 3T3-F442A cells with Adamts5 knockdown were significantly smaller as compared to controls. After 15 or 25 weeks on HFD, total body weight and subcutaneous AT weight were similar for Adamts5(+/+) and Adamts5(-/-) mice, but visceral/gonadal fat mass was significantly lower for Adamts5(-/-) mice. These data were confirmed by magnetic resonance imaging. In addition, the blood vessel density in adipose tissue was higher for Adamts5(-/-) mice kept on HFD. In conclusion, our data support the concept that ADAMTS5 promotes adipogenesis in vitro and in vivo, as well as development of visceral AT and associated angiogenesis in mice kept on HFD.

Entities:  

Keywords:  ADAMTS5; Adipogenesis; adipose tissue; aggrecanase; obesity

Mesh:

Substances:

Year:  2016        PMID: 27383908     DOI: 10.1160/TH16-01-0015

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Adiposity and metabolic health in mice deficient in intestinal alkaline phosphatase.

Authors:  Ellen Vercalsteren; Christine Vranckx; H Roger Lijnen; Bianca Hemmeryckx; Ilse Scroyen
Journal:  Adipocyte       Date:  2018-08-10       Impact factor: 4.534

2.  ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

Authors:  HaiFeng Yang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2022-01-24

3.  Functional role of ADAMTS5 in adiposity and metabolic health.

Authors:  Dries Bauters; Pierre Bedossa; Henri Roger Lijnen; Bianca Hemmeryckx
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

4.  Loss of ADAMTS5 enhances brown adipose tissue mass and promotes browning of white adipose tissue via CREB signaling.

Authors:  Dries Bauters; Mathias Cobbaut; Lotte Geys; Johan Van Lint; Bianca Hemmeryckx; H Roger Lijnen
Journal:  Mol Metab       Date:  2017-05-10       Impact factor: 7.422

5.  Construction of a high-density genetic map and fine QTL mapping for growth and nutritional traits of Crassostrea gigas.

Authors:  Chunyan Li; Jinpeng Wang; Kai Song; Jie Meng; Fei Xu; Li Li; Guofan Zhang
Journal:  BMC Genomics       Date:  2018-08-22       Impact factor: 3.969

6.  Does butein affect adipogenesis?

Authors:  Bianca Hemmeryckx; Christine Vranckx; Dries Bauters; H Roger Lijnen; Ilse Scroyen
Journal:  Adipocyte       Date:  2019-12       Impact factor: 4.534

7.  TGF-Beta Induced Key Genes of Osteogenic and Adipogenic Differentiation in Human Mesenchymal Stem Cells and MiRNA-mRNA Regulatory Networks.

Authors:  Genfa Du; Xinyuan Cheng; Zhen Zhang; Linjing Han; Keliang Wu; Yongjun Li; Xiaosheng Lin
Journal:  Front Genet       Date:  2021-11-25       Impact factor: 4.599

Review 8.  Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases.

Authors:  Francisco Javier Ruiz-Ojeda; Andrea Méndez-Gutiérrez; Concepción María Aguilera; Julio Plaza-Díaz
Journal:  Int J Mol Sci       Date:  2019-10-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.